Live Science on MSN

'Groundbreaking' gene therapy is first treatment for Huntington's disease to slow the condition

Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the ...

Experimental gene therapy found to slow Huntington’s disease progression, company says

An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” study, according to ...

New Treatment Shows Promise for Huntington’s Disease

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported.
Medical Dialogues

Subthalamic DBS as an Effective Therapy for Parkinson's Disease: JAMA

A recent trial published in the Journal of American Medical Association found that subthalamic deep brain stimulation (DBS) ...
TCTMD

ESTREL: Levodopa Doesn’t Boost Rehab Benefits After Acute Stroke

The trial’s findings will dampen enthusiasm for the drug in stroke recovery, though research questions remain, one expert ...

First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel

PDite-2 is the first Phase III pivotal clinical trial for an investigational allogeneic pluripotent stem cell derived therapy ...
PharmaTimes

First patient treated in pivotal trial of Parkinson’s cell therapy

BlueRock Therapeutics has dosed the first patient in its pivotal phase 3 trial of bemdaneprocel, an investigational cell ...
University of Delaware

How pain impacts motor learning

Susanne Morton has spent more than two decades studying motor learning. Morton is an associate professor in the Department of Physical Therapy (PT) at the University of Delaware’s College of Health ...